Not sure if you're familiar with Linkedin website but if you have an account you can follow GCAN's Aitan or Symtomax's Paul Segal. They post updates on Symtomax's progress. Looks like Aitan follows Paul's updates over at Symtomax. A press release would definitely be welcomed at this point.